EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells. [electronic resource]
Producer: 20061103Description: 215-23 p. digitalISSN:- 1061-186X
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- administration & dosage
- Caco-2 Cells
- Cell Line, Tumor
- Cetuximab
- Colorectal Neoplasms -- metabolism
- Doxorubicin -- administration & dosage
- Drug Delivery Systems
- ErbB Receptors -- immunology
- Humans
- Immunoglobulin Fab Fragments -- administration & dosage
- Liposomes -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.